Stratified treatment and management of adenomyosis

doi:10.3785/j.issn.1008-9292.2019.04.01

J Zhejiang Univ (Med Sci)

2019, Vol. 48

Issue (2): 123-129 DOI: 10.3785/j.issn.1008-9292.2019.04.01

Stratified treatment and management of adenomyosis

ZHANG Xinmei(

),XU Ping

Department of Gynecology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China

Download:

HTML( 43 )

PDF(1005KB)
Export: BibTeX | EndNote (RIS)

Abstract

In recent years, surgical and non-surgical excision and drug therapy have replaced hysterectomy as the main therapeutic modalities for adenomyosis. It is suggested that the precise clinical diagnosis should be based on the reconstruction of digitized three-dimensional model with original image data of adenomyosis. Patients' age and clinical manifestations should also be considered, and the patients should be stratified according to reproductive requirements, so as to determine the best treatment. In view of the infiltration and diffuse growth of adenomyosis lesions in the myometrium of the uterus, it is suggested that long-term drug management should be adopted after surgical or non-surgical lesion resection.Gonadotropin releasing hormone agonists, levonorgestrel-releasing intrauterine system, dienogest and short-acting oral contraceptives should be recommended to consolidate the curative effect in order to delay the progress of the disease and prevent recurrence.

Key words： Adenomyosis/pathology Adenomyosis/diagnostic imaging Adenomyosis/surgery Adenomyosis/drug therapy Combined modality therapy

Received: 26 January 2019 Published: 24 July 2019

CLC:

R711.74

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Xinmei
	XU Ping

Cite this article:

ZHANG Xinmei,XU Ping. Stratified treatment and management of adenomyosis. J Zhejiang Univ (Med Sci), 2019, 48(2): 123-129.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2019.04.01 OR http://www.zjujournals.com/med/Y2019/V48/I2/123

子宫腺肌病分层治疗及管理

近年来，手术病灶切除、非手术病灶切除及药物治疗已代替子宫切除术成为子宫腺肌病的主要治疗方式。临床上建议基于子宫腺肌病影像学数据重建数字化三维模型进行临床精准诊断，综合考虑患者年龄、临床表现，以及是否有生育要求进行子宫腺肌病患者的临床分层，同时遵守个体化原则，选择最佳治疗方案。鉴于子宫腺肌病病灶在子宫肌层内呈现浸润弥漫生长，建议手术病灶切除、非手术病灶切除方法治疗后采用药物长期管理，推荐促性腺激素释放激素激动剂、左炔诺孕酮宫内节育系统、地诺孕素以及短效口服避孕药等药物巩固疗效，以延缓疾病进展，防止复发。

关键词： 子宫腺肌病/病理学, 子宫腺肌病/影像诊断, 子宫腺肌病/外科学, 子宫腺肌病/药物疗法, 综合疗法

Fig 1 Three-dimensional reconstruction digital model of adenomyosis

Fig 2 Clinical pathway of diagnosis and treatment based on three-dimensional reconstruction digital model of adenomyosis

Fig 3 Long-term postoperative management mode of adenomyosis


[1]	LAZZERI L , MOROSETTI G , CENTINI G et al. A sonographic classification of adenomyosis:interobserver reproducibility in the evaluation of type and degree of the myometrial involvement[J]. Fertil Steril, 2018, 110 (6): 1154- 1161 doi: 10.1016/j.fertnstert.2018.06.031

[2]	CANIS M , GREMEAU A S , BOURDEL N . Elusive adenomyosis:a plea for an international classification system to allow artificial intelligence approaches to reset our clinical management[J]. Fertil Steril, 2018, 110 (6): 1039- 1040 doi: 10.1016/j.fertnstert.2018.08.008

[3]	CUNNINGHAM R K , HORROW M M , SMITH R J et al. Adenomyosis:a sonographic diagnosis[J]. Radiographics, 2018, 38 (5): 1576- 1589 doi: 10.1148/rg.2018180080

[4]	STOELINGA B , WJK H , NIEUWENHUIS L L et al. Accuracy and reproducibility of sonoelastography for the assessment of fibroids and adenomyosis, with magnetic resonance imaging as reference standard[J]. Ultrasound Med Biol, 2018, 44 (8): 1654- 1663 doi: 10.1016/j.ultrasmedbio.2018.03.027

[5]	BAZOT M , DARA? E . Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis[J]. Fertil Steril, 2018, 109 (3): 389- 397 doi: 10.1016/j.fertnstert.2018.01.024

[6]	GORDTS S , GRIMBIZIS G , CAMPO R . Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis[J]. Fertil Steril, 2018, 109 (3): 380- 388 doi: 10.1016/j.fertnstert.2018.01.006

[7]	HUANG X , HUANG Q , CHEN S et al. Efficacy of laparoscopic adenomyomectomy using double-flap method for diffuse uterine adenomyosis[J]. BMC Womens Health, 2015, 15:24 doi: 10.1186/s12905-015-0182-5

[8]	SHIN Y J , KWAK D W , CHUNG J H et al. The risk of preterm births among pregnant women with adenomyosis[J]. J Ultrasound Med, 2018, 37 (8): 1937- 1943 doi: 10.1002/jum.v37.8

[9]	TAMURA H , KISHI H , KITADE M et al. Complications and outcomes of pregnant women with adenomyosis in Japan[J]. Reprod Med Biol, 2017, 16 (4): 330- 336 doi: 10.1002/rmb2.12050

[10]	TAMURA H , KISHI H , KITADE M et al. Clinical outcomes of infertility treatment for women with adenomyosis in Japan[J]. Reprod Med Biol, 2017, 16 (3): 276- 282 doi: 10.1002/rmb2.12036

[11]	BUGGIO L , MONTI E , GATTEI U et al. Adenomyosis:fertility and obstetric outcome. A comprehensive literature review[J]. Minerva Ginecol, 2018, 70 (3): 295- 302

[12]	HASHIMOTO A , IRIYAMA T , SAYAMA S et al. Adenomyosis and adverse perinatal outcomes:increased risk of second trimester miscarriage, preeclampsia, and placental malposition[J]. J Matern Fetal Neonatal Med, 2018, 31 (3): 364- 369 doi: 10.1080/14767058.2017.1285895

[13]	朱琴, 张红霞, 刘霞 et al. 子宫内膜异位症术后应用不同治疗周期半剂量促性腺激素释放激素激动剂的疗效观察[J]. 中华全科医师杂志, 2013, 12 (2): 140- 142 ZHU Qin , ZHANG Hongxia , LIU Xia et al. Uses of half-dose gonadotropin-releasing hormone agonist with different treatment cycles after conservative laparoscopic surgery in the treatment of endometriosis[J]. Chinese Journal of General Practitioners, 2013, 12 (2): 140- 142 doi: 10.3760/cma.j.issn.1671-7368.2013.02.025

[14]	吴光平, 蒲元芳, 陈锦云 et al. 高强度聚焦超声消融治疗子宫后壁腺肌病的安全性及疗效观察[J]. 临床超声医学杂志, 2015, 17 (5): 348- 350 WU Guangping , PU Yuanfang , CHEN Jinyun et al. Therapeutic effect and safety of high intensity focused ultrasound for the ablation of posterior uterine adenomyosis[J]. Journal of Ultrasound in Clinical Medicine, 2015, 17 (5): 348- 350

[15]	尹格平, 陈铭, 朱彤宇 et al. 射频热凝固微创治疗子宫肌腺瘤和腺肌病[J]. 中国妇产科临床杂志, 2003, 4 (6): 410- 412 YIN Geping , CHEN Ming , ZHU Tongyu et al. Radiofrequency heat coagulation minimal invasive treatment of adenomyoma and adenomyosis of uterus[J]. Chinese Journal of Clinical Obstetrics and Gynecology, 2003, 4 (6): 410- 412 doi: 10.3969/j.issn.1672-1861.2003.06.003

[16]	ROCHA T P , ANDRES M P , BORRELLI G M et al. Fertility-sparing treatment of adenomyosis in patients with infertility:a systematic review of current options[J]. Reprod Sci, 2018, 25 (4): 480- 486 doi: 10.1177/1933719118756754

[17]	MAP O , CRISPI C P , BROLLO L C et al. Surgery in adenomyosis[J]. Arch Gynecol Obstet, 2018, 297 (3): 581- 589 doi: 10.1007/s00404-017-4603-6

[18]	OSADA H . Uterine adenomyosis and adenomyoma:the surgical approach[J]. Fertil Steril, 2018, 109 (3): 406- 417 doi: 10.1016/j.fertnstert.2018.01.032

[19]	KWACK J Y , IM K S , KWON Y S . Conservative surgery of uterine adenomyosis via laparoscopic versus laparotomic approach in a single institution[J]. J Obstet Gynaecol Res, 2018, 44 (7): 1268- 1273 doi: 10.1111/jog.13658

[20]	YOUNES G , TULANDI T . Conservative surgery for adenomyosis and results:a systematic review[J]. J Minim Invasive Gynecol, 2018, 25 (2): 265- 276 doi: 10.1016/j.jmig.2017.07.014

[21]	NERⅡSHI K , HIRATA T , FUKUDA S et al. Long-term dienogest administration in patients with symptomatic adenomyosis[J]. J Obstet Gynaecol Res, 2018, 44 (8): 1439- 1444 doi: 10.1111/jog.2018.44.issue-8

[22]	OSUGA Y , FUJIMOTO-OKABE H , HAGINO A . Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis:a randomized, double-blind, multicenter, placebo-controlled study[J]. Fertil Steril, 2017, 108 (4): 673- 678 doi: 10.1016/j.fertnstert.2017.07.021

[23]	中国医师协会妇产科医师分会子宫内膜异位症专业委会, 中华医学会妇产科分会子宫内膜异位症协作组 . 子宫内膜异位症长期管理中国专家共识[J]. 中华妇产科杂志, 2018, 53 (12): 836- 841 Professional Committee on Endometriosis of Obstetricians and Gynecologists Branch of Chinese Medical Doctor Association , Endometriosis Collaboration Group of Obstetrics and Gynecology Branch of Chinese Medical Association . Expert consensus on long-term management of endometriosis in China[J]. Chinese Journal of Obstetrics and Gynecology, 2018, 53 (12): 836- 841 doi: 10.3760/cma.j.issn.0529-567x.2018.12.007

[24]	HORNG H C , CHEN C H , CHEN C Y et al. Uterine-sparing surgery for adenomyosis and/or adenomyoma[J]. Taiwan J Obstet Gynecol, 2014, 53 (1): 3- 7

[25]	DE BRUIJN A M , SMINK M , WJK H et al. Uterine artery embolization for symptomatic adenomyosis:7-year clinical follow-up using UFS-Qol questionnaire[J]. Cardiovasc Intervent Radiol, 2017, 40 (9): 1344- 1350 doi: 10.1007/s00270-017-1686-1

[26]	ZHOU J, HE L, LIU P, et al. Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: a long-term follow-up study of 252 cases[J/OL]. PLoS One, 2016, 11(11): e0165610.

[27]	GONG C , SETZEN R , LIU Z et al. High intensity focused ultrasound treatment of adenomyosis:The relationship between the features of magnetic resonance imaging on T2 weighted images and the therapeutic efficacy[J]. Eur J Radiol, 2017, 89:117- 122 doi: 10.1016/j.ejrad.2017.02.001

[1]	ZHANG Jianmin. Advances in surgical treatment of ischemic cerebrovascular disease[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 233-240.

[2]	LOU Junyao,HUANG Xiufeng,ZHANG Lifeng,XU Ping,ZHANG Xinmei,CHEN Zhengyun. The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 136-141.

[3]	ZHANG Lifeng,YANG Hui,ZHANG Xinmei,CHEN Zhengyun. Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 130-135.

[4]	LIN Zuodong,LANG Dehai. Efficacy of percutaneous mechanical thrombectomy combined with percutaneous transluminal angioplasty in treatment of iliofemoral deep vein thrombosis[J]. J Zhejiang Univ (Med Sci), 2018, 47(6): 595-600.

[5]	YE Wan-li，et al. Concurrent chemoradiotherapy for locally advanced unresectable extrahepatic cholangiocarcinoma: a report of 19 cases[J]. J Zhejiang Univ (Med Sci), 2014, 43(6): 688-694.

[6]	. Combination of canales sacralis drop with acupotomy dissolution in treatment of discogenic lumbocrural pain[J]. J Zhejiang Univ (Med Sci), 2011, 40(1): 90-93.

Viewed

Full text

Abstract

Cited

Shared

Discussed